Sign up
Log in
Crude Oil Down 4%; Dollar Tree Earnings Top Views
Share
Listen to the news

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.

The Dow traded up 0.89% to 46,973.92 while the NASDAQ rose 1.35% to 22,404.50. The S&P 500 also rose, gaining, 1.07% to 6,703.37.

Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 Earnings

Leading and Lagging Sectors

Financial shares climbed by 1.6% on Monday.

In trading on Monday, energy stocks rose by just 0.2%.

Top Headline

Dollar Tree, Inc. (NASDAQ:DLTR) reported upbeat earnings for the fourth quarter on Monday.

The company posted quarterly earnings of $2.56 per share which beat the analyst consensus estimate of $2.52 per share. The company reported quarterly sales of $5.451 billion compared to the analyst consensus estimate of $5.462 billion.

Dollar Tree said it sees FY2026 adjusted EPS of $6.50-$6.90 versus market estimates of $6.69. The company sees sales of $20.500 billion-$20.700 billion, versus estimates of $20.690 billion.

Equities Trading UP
           

  • Urgent.ly Inc (NASDAQ:ULY) shares shot up 164% to $5.36 after the company announced it entered into an agreement to be acquired by Agero for $5.50 in cash per share.Also, the company reported better-than-expected fourth-quarter financial results.
  • Shares of CytomX Therapeutics Inc (NASDAQ:CTMX) got a boost, surging 56% to $7.28 after the company reported fourth-quarter results and announced Phase 1 expansion data for EpCAM PROBODY ADC, Varseta-M in late-line metastatic CRC.
  • Hcw Biologics Inc (NASDAQ:HCWB) shares were also up, gaining 92% to $0.99 after the company announced results for HCW9206 production platform for CAR-T cell therapies.

Equities Trading DOWN

  • Zepp Health Corp – ADR (NYSE:ZEPP) shares dropped 20% to $16.69. Zepp Health reported quarterly losses of 40 cents per share, versus year-ago losses of $1.40 per share. The company reported $85.165 million in sales, up from $59.542 million in the year-ago period.
  • Shares of Nasus Pharma Ltd (NYSE:NSRX) were down 38% to $3.09 after the company announced top line data from Phase 2 clinical study of NS002.
  • Sealsq Corp (NASDAQ:LAES) was down, falling 12% to $3.40 after the company announced a $125 million offering of 30.4 million shares with warrants.

Commodities

In commodity news, oil traded down 4.1% to $94.71 while gold traded down 0.7% at $5,028.10.

Silver traded down 0.1% to $81.245 on Monday, while copper rose 1.1% to $5.8205.

Euro zone

European shares were higher today. The eurozone's STOXX 600 rose 0.8%, while Spain's IBEX 35 Index rose 0.9%. London's FTSE 100 rose 1.1%, Germany's DAX gained 0.9% and France's CAC 40 rose 0.6% during the session.

Asia Pacific Markets

Asian markets closed mixed on Monday, with Japan's Nikkei 225 falling 0.13%, Hong Kong's Hang Seng index gaining 1.45%, China's Shanghai Composite slipping 0.26% and India's BSE Sensex gaining 1.26%.

Economics

  • The NY Empire State Manufacturing Index declined to -0.2 in March from 7.1 in the previous month, down from market estimates of 3.2.
  • The NAHB/Wells Fargo Housing Market Index rose to 38 in March from 37 in the previous month, versus market estimates of 37.
  • U.S. industrial production rose 0.2% month-over-month in February, compared to market estimates of 0.1%.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.